Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
DV7O1M
|
|||
| Drug Name |
ProTmune
|
|||
| Drug Type |
Cell therapy
|
|||
| Indication | Refractory hematologic malignancy [ICD-11: 2A85.5; ICD-10: C83.1] | Phase 1/2 | [1] | |
| Company |
Fate Therapeutics
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT02743351) Study of ProTmune for Allogeneic HCT in Adult Patients With Hematologic Malignancies. U.S. National Institutes of Health. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.